Featured Research

from universities, journals, and other organizations

American women view STD vaccine positively, survey finds

Date:
August 24, 2010
Source:
Indiana University School of Medicine
Summary:
Cost but not convenience plays a significant role in attitudes about vaccination for common human papillomaviruses for women over the age of 26, according to the authors of a recent article. Researchers surveyed 1,323 women between 27 and 55 years of age who represent a racial and demographic cross section of the United States to determine the willingness among adult women to be vaccinated.

Cost but not convenience plays a significant role in attitudes about vaccination for common human papillomaviruses for women over the age of 26, according to the authors of a recent article in the journal Sexual Health.

Currently, the two vaccines for human papillomavirus (HPV), which is the primary cause of cervical cancer, are U.S. Food and Drug Administration approved for females from 9 to 26 years of age. The vaccines, Gardasil (Merck and Co.) and Cervarix (GlaxoSmithKline) are under review by the FDA for an older population of women.

Researchers from Indiana University School of Medicine and Columbia University Medical Center surveyed 1,323 women between 27 and 55 years of age who represent a racial and demographic cross section of the United States to determine the willingness among adult women to be vaccinated.

"We have been involved for several years in research looking at the attitudes toward HPV vaccination and acceptance of vaccine," said senior author and co-principal investigator Gregory D. Zimet, Ph.D., professor of pediatrics and clinical psychology in the Section of Adolescent Medicine at the IU School of Medicine. "This project looked at an older population of women to determine their attitudes about HPV vaccination and what factors influenced their attitudes."

Researchers found moderately strong interest in receiving the vaccination if it is available free of charge, said first author Nathan W. Stupiansky, Ph.D., a fellow with the IU Department of Pediatrics, Section of Adolescent Medicine. As out-of-pocket costs increased, interest decreased for the vaccine, which typically costs $120 per dose and requires three doses.

The survey also queried women as to whether they would prefer receiving the vaccine at a doctor's office or a local pharmacy to gauge if convenience played a factor in acceptance. The preferred choice by a slight edge was a doctor's office.

Factors that did not increase interest in the vaccine included having a friend or relative who had cervical cancer or personally having had a prior sexually transmitted infection.

Increased acceptibility was found in women who had experienced a genital warts outbreak, had at least one abnormal Pap test, previously had heard about the HPV vaccine or who had had a flu shot within the past two years.

"With the accumulating empirical evidence that vaccination of women over the age of 26 can be beneficial, it is important to understand specific factors associated with HPV vaccine acceptability," said Dr. Stupiansky. "This study clarifies some of the issues for acceptance including cost and prior knowledge of the vaccine.

The findings of the research also suggest that interest in the vaccine among adult women may be substantially dampened if insurance coverage does not reduce the out-of-pocket costs of HPV vaccination. Health insurance and/or public financing (the Vaccine for Children Program) covers HPV vaccination costs for virtually all females 9 through 17 years of age.

HPV is the most common sexually transmitted infection in the U.S. and can be found in more than 25 percent of all women aged 14 to 59 years. The highest rates are among women between the ages of 20 and 24 years but remain above 25 percent for women up to age 49. An estimated 1.6 million new infections occur each year in women older than 26 years of age. HPV is responsible for all cases of cervical cancer and genital warts and is the cause of some cases of anal, throat, vulvar and vaginal cancers.

This study was supported by an investigator-initiated grant from Merck and Co.


Story Source:

The above story is based on materials provided by Indiana University School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nathan W. Stupiansky, Susan L. Rosenthal, Sarah E. Wiehe and Gregory D. Zimet. Human papillomavirus vaccine acceptability among a national sample of adult women in the USA. Sexual Health, 2010; 7 (3): 304 DOI: 10.1071/SH09127

Cite This Page:

Indiana University School of Medicine. "American women view STD vaccine positively, survey finds." ScienceDaily. ScienceDaily, 24 August 2010. <www.sciencedaily.com/releases/2010/08/100824121024.htm>.
Indiana University School of Medicine. (2010, August 24). American women view STD vaccine positively, survey finds. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2010/08/100824121024.htm
Indiana University School of Medicine. "American women view STD vaccine positively, survey finds." ScienceDaily. www.sciencedaily.com/releases/2010/08/100824121024.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins